References
Jovanovic L, Peterson CM: The clinical utility of glycosylated haemoglobin. Am J Med 70: 331–338, 1981
Snyder S, Ashwell G: Quantitation of specific serum glycoproteins in malignancy. Clin Chim Acta 34: 449–455, 1971
Mattison P, Cove DH, Walsh L, Howell A, McConkey B, Morrison JM: Serum proteins as tumour markers for breast cancer. Br J Cancer 43: 542–545, 1981
Hogan-Ryan A, Fennely JJ, Jones M, Cantwell B, Duffy MJ: Serum sialic acid and CEA concentrations in human breast cancer. Br J Cancer 41: 587–592, 1980
Davis JC, Hipkin LJ, Finn R, St Hill CA: Do plasma glycoproteins induce lymphocyte hyporesponsiveness and insulin resistance? Lancet ii: 1343–1345, 1978
Kocak M, Hipkin LJ, Davis JC: Glycosylated haemoglobins in advanced malignancy. Europ J Cancer 17: 123–124, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cantwell, B., Shirley, I.F. & Fennelly, J.J. Glycosylated haemoglobin levels in breast cancer patients receiving cytotoxic chemotherapy. Breast Cancer Res Tr 1, 281–282 (1981). https://doi.org/10.1007/BF01806270
Issue Date:
DOI: https://doi.org/10.1007/BF01806270